Catherine Thieblemont
MD, PhD
Head, Hemato-Oncology Department
👥Biography 个人简介
Catherine Thieblemont leads hemato-oncology at Saint-Louis Hospital in Paris and was principal investigator of the pivotal EPCORE NHL-1 epcoritamab trial in relapsed DLBCL. She has led French and international bispecific studies. Her work has helped establish bispecific standards in aggressive lymphoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Catherine Thieblemont 的研究动态
Follow Catherine Thieblemont's research updates
留下邮箱，当我们发布与 Catherine Thieblemont（Hopital Saint-Louis, Universite Paris Cite）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment